These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 232620)

  • 21. Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin.
    Glode LM; Jacques A; Mergenhagen SE; Rosenstreich DL
    J Immunol; 1977 Jul; 119(1):162-6. PubMed ID: 326955
    [No Abstract]   [Full Text] [Related]  

  • 22. Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions.
    Meltzer MS; Ruco LP; Boraschi D; Nacy CA
    J Reticuloendothel Soc; 1979 Oct; 26(4):403-15. PubMed ID: 390144
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhancement of O2- generation and tumoricidal activity of murine macrophages by a monosaccharide precursor of Escherichia coli lipid A.
    Amano F; Nishijima M; Akagawa K; Akamatsu Y
    FEBS Lett; 1985 Nov; 192(2):263-6. PubMed ID: 2998869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of macrophage effector functions: bactericidal versus tumoricidal activities.
    Campbell PA; Czuprynski CJ; Cook JL
    J Leukoc Biol; 1984 Sep; 36(3):293-306. PubMed ID: 6384403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
    Poste G
    Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.
    Ruco LP; Meltzer MS; Rosenstreich DL
    J Immunol; 1978 Aug; 121(2):543-8. PubMed ID: 681749
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid.
    Chapman HA; Hibbs JB
    Science; 1977 Jul; 197(4300):282-5. PubMed ID: 195338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor.
    Männel DN; Falk W; Meltzer MS
    Infect Immun; 1981 Jul; 33(1):156-64. PubMed ID: 7021422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
    [No Abstract]   [Full Text] [Related]  

  • 30. Macrophages as cytotoxic effector cells.
    Lohmann-Matthes ML; Lang H; Sun D
    Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells.
    Leonard EJ; Ruco LP; Meltzer MS
    Cell Immunol; 1978 Dec; 41(2):347-57. PubMed ID: 31981
    [No Abstract]   [Full Text] [Related]  

  • 32. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
    Hogan MM; Vogel SN
    J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage sensitivity to endotoxin: genetic control by a single codominant gene.
    Rosenstreich DL; Vogel SN; Jacques AR; Wahl LM; Oppenheim JJ
    J Immunol; 1978 Nov; 121(5):1664-70. PubMed ID: 101590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of specific macrophage cytotoxicity.
    De Weger RA; Den Otter W
    Methods Enzymol; 1986; 132():531-6. PubMed ID: 3547024
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
    Leu RW; Rummage JA; Rahimi MB; Herriott MJ
    Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro studies on the tumour cytotoxicity of normal, stimulated and immunologically activated mouse macrophages.
    Hansen JG; Bennedsen J; Rhodes JM; Larsen SO
    Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):27-32. PubMed ID: 7080837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of tumoricidal and/or suppressor macrophages: different stimulatory signals trigger either function both in vivo and in vitro.
    Taramelli D; Bagley MB; Holden HT; Varesio L
    Adv Exp Med Biol; 1982; 155():487-92. PubMed ID: 6218736
    [No Abstract]   [Full Text] [Related]  

  • 39. Endotoxin (LPS) stimulates in vitro migration of macrophages from LPS-resistant mice but not from LPS-sensitive mice.
    Verghese MW; Snyderman R
    J Immunol; 1982 Feb; 128(2):608-13. PubMed ID: 7054291
    [No Abstract]   [Full Text] [Related]  

  • 40. Ganglioside expression in macrophages from endotoxin responder and nonresponder mice.
    Yohe HC; Ryan JL
    J Immunol; 1986 Dec; 137(12):3921-7. PubMed ID: 3537127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.